Viewing Study NCT02216669


Ignite Creation Date: 2025-12-24 @ 11:00 PM
Ignite Modification Date: 2025-12-25 @ 8:29 PM
Study NCT ID: NCT02216669
Status: WITHDRAWN
Last Update Posted: 2017-03-03
First Post: 2014-08-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Trial to Determine Optimal Phase II Dose of the Oral Dual CAIX Inhibitor/ Radiosensitizer
Sponsor: Maastricht Radiation Oncology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module